Found a bit of relevant data re Geva's holding:
From the ANN on 13 August 2020 before delisting (https://hotcopper.com.au/threads/ann-g-medical-seeks-delisting-to-pursue-q4-nasdaq-listing.5555237/), page41, Directors' Interests in Securities, Dr Yacov Geva has 301,388,307 No. of Shares.
From the Appendix 2A on 30/09/2020 (https://hotcopper.com.au/threads/ann-appendix-2a.5657036/), page 8, Total number of +securities on issue - 841,446,783 (excluding unquoted securities).
So roughly Dr Geva's holding percentage is ~ 35.82% before delisting from the above numbers. Consolidation doesn't change the percentage we all know so his percentage remains the same. As per "The Offering" file, after two consolidations (90:1), the pre-ipo ordinary shares outstanding is 10,414,684 plus 3,000,000 Shares Offered.
- Forums
- ASX - By Stock
- GMV
- IPO update
IPO update, page-29
-
- There are more pages in this discussion • 1,541 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online